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Depression is a common mental health problem, with 10%
of the adult population affected at any one time.1-4 The
Patient Health Questionnaire-9 (PHQ-9)5 was designed as a
case-ﬁnding instrument for depression in primary care and
has been tested in a range of populations.6-9 The shorter
version, Patient Health Questionnaire-2 (PHQ-2)10 contains
two key items of the PHQ-9 and is now well established as a
sufﬁcient measure of screening for depression.11,12
The PHQ-9 was developed and assessed using
traditional psychometric attributes that are underpinned
by classical test theory (CTT), which is the mostly widely
used method for constructing and evaluating rating scales.
Despite its prevalence, CTT has some limitations, including
that ordinal data are treated as interval level, the
evaluations of scales are sample dependent, and the
assumptions of CTT cannot be formally tested.13
Recent advances in the application of modern psycho-
metric methodology (e.g. Rasch modelling)14 provide a useful
supplement to traditional psychometric methods. Rasch
analysis is the formal testing of an outcome scale against a
mathematical measurement model that operationalises
formal measurement.15 The Rasch model shows what should
be expected in responses to items if interval measurement is
to be achieved, and provides a proper method for non-linear
transformation of ordinal raw scores to interval measures.15,16
The PHQ-9 has not been evaluated using Rasch
analysis on a sample of adults with depression in primary
care services. Furthermore, the scale has not been fully
examined in terms of the underlying assumptions of local
independency. We have set out to address this.
Method
Participants
A cross-sectional sample of 767 participants were recruited
as part of the Randomised Evaluation of the Effectiveness
and Acceptability of Computerised Therapy (REEACT)
trial (www.york.ac.uk/healthsciences/research/mental-
health/projects/reeact/). Participants were included if they
were: (a) adults aged 18 years and above; (b) diagnosed with
depression; and (c) not currently in receipt of computerised
cognitive-behavioural therapy (CBT) or specialist psycho-
logical therapy. Patients were excluded if they were: (a)
actively suicidal; (b) experiencing psychotic symptoms; (c)
were diagnosed previously with post-natal depression; (d)
recently bereaved; and (e) had psychotic depression. PHQ-9
data are available for all 767 screened participants, but
demographic information is only available for the participants
who were entered into the study (n = 695). Of those, a third
were male (n = 229) and 95% (n = 657) were of White
ethnic origin. The mean age was 39.8 years (s.d. = 12.7;
range 18.5-76.2).
Measure
The PHQ-9 is a nine-item measure of depressive symptoms
containing four somatic items (items 3, 4, 5 and 8) and ﬁve
items relating to thoughts and feelings linked to depressed
mood (items 1, 2, 6, 7 and 9). Respondents are asked to
report on the frequency of their symptoms during the past
2 weeks using four response categories: 0 (not at all), 1
(several days), 2 (more than half the days) and 3 (nearly
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Aims and method To explore the modern psychometric properties of the Patient
Health Questionnaire (PHQ-9), we used the Rasch analysis in a sample of 767
primary care patients with depression.
Results The analysis highlighted dependency issues between items 1 and 2 (‘Little
interest or pleasure in doing things’ and ‘Feeling down, depressed, or hopeless’), and
items 3 and 4 (‘Trouble falling or staying asleep, or sleeping too much’ and ‘Feeling
tired or having little energy’). Items 1 and 2 displayed an over-discrimination,
suggesting their potential redundancy within the complete item set.
Clinical implications In its current format the PHQ-9 displays some problems with
regard to its measurement structure among a sample of primary care patients. These
problems can be addressed by removing potentially redundant items to deliver a
stable screening tool. The results also lend support for the PHQ-2 to be used as a
screening tool in a primary care setting.
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every day). The total score ranges from 0 to 27, and the
recommended cut-off point to classify clinical depression is
a score of 10. The PHQ-9 has consistently demonstrated
robust psychometric properties, reliability and validity in
adult populations.17-19
Procedures
Administration of the PHQ-9 was conducted at baseline
(prior to randomisation), and at 4, 12 and 24 months
post-randomisation as part of a battery of tests for the
larger REEACT study during the recruitment period.
Trained interviewers at each of the four trial sites
(York, Manchester, Bristol and Shefﬁeld) read or asked
participants to self-report their responses on the PHQ-9
items and recorded the responses. The data included all
screened participants (n = 767).
Rasch analysis
Analysis was conducted on the entire baseline sample
(n = 767) using RUMM 2030 software (www.rummlab.
com.au) using the partial credit (unrestricted) parameter-
isation of the model.20 Assessing the internal construct
validity of the PHQ-9 involved investigating the individual
item thresholds, the overall scale ﬁt, individual item ﬁt to
the measurement model and issues relating to the local
independency assumptions. The response structure across
all items was investigated to assess whether it was working
as intended. This was explored by assessing the thresholds
at the cross-over points between adjacent response
categories, which should remain ordered in a logical
pattern.16 The overall scale ﬁt statistics provide a summary
measure of how the scale conforms to Rasch model
expectations. Reliability indices are delivered in the form
of a person separation index (PSI) and Cronbach’s alpha.
Analysis was also conducted at the individual item level,
where adequate ﬁt is indicated by non-signiﬁcant chi-
squared test values and z-standardised ﬁt residual statistics
within +/72.5.21 High positive ﬁt residual values indicate a
misﬁt to model expectations, while high negative ﬁt
residuals may suggest item redundancy.22
A residual correlation matrix was used to explore the
extent of dependency between items within the scale.
Dependency occurs when the response to one item has a
direct effect on the response to another item within the
scale, conditional on the level of depression. If present, this
is liable to artiﬁcially inﬂate reliability indices and to create
spurious multidimensionality within an item set.22,23
Residual correlations above a value of 0.2 indicate a
signiﬁcant level of dependency between items,24 although
values above 0.1 have been used to identify potential
response dependency.23 Response dependency can be
accounted for by grouping the dependent items together
into ‘sub-tests’ within the analysis framework.
The unidimensionality of the scale was assessed using a
t-test procedure25 whereby the percentage of signiﬁcant
individual t-tests should not be above 5%. In practice, the
lower bound of a binomial conﬁdence interval should
overlap the 5% level to indicate an acceptable absence of
multidimensionality within the scale.15
The targeting of a scale to the study sample is assessed
by investigating the relative logit locations of the item
threshold distribution and person location distribution. The
primary purpose of scales may differ, but for a well-targeted
measure, the mean person location should not deviate too
much from the mean item difﬁculty (ﬁxed at 0 logits).15 This
distribution is also reﬂected in the Person-Item Threshold
Distribution plot available in the RUMM2030 software.
The second element of the analysis involved the
exploration of ways to account for any misﬁt found within
the scale and offers further insight into the contributions of
each individual item. Iterations of the analyses involved a
combination of item removal or sub-testing to account for
response dependency.
Results
Part one: PHQ-9 assessment
The sample of 767 contained a full range of scores (0-27)
with no missing data (median 16; interquartile range 7).
Over 90% (n = 695) scored above the cut-off point for
clinical depression (i.e. a score of 10 or over).
Thresholds of individual items
None of the items displayed reversed/disordered thresholds,
meaning that the original PHQ-9 response structure
appears to be functioning as intended. The threshold
marking the lower boundary of the scale is the transition
from response category 0 (not at all) to response category 1
(several days) on item 2. The threshold marking the upper
boundary of the scale is the transition from response
category 2 (more than half the days) to category 3 (nearly
every day) on item 9.
Initial fit to the Rasch measurement model
All iterations of the analysis are summarised in Tables 1a
and 1b.
Summary fit statistics
The summary statistics of the initial analysis (Table 1a, 1b)
suggested some misﬁt within the scale as indicated by a
signiﬁcant w2 item-trait interaction term and a high-item ﬁt
residual standard deviation. The series of t-tests suggest
that the item set was not unidimensional; however, this can
also be heavily inﬂuenced by the response dependency
within an item set. This led to an exploration of the
individual item ﬁt.
The initial analysis ﬁt statistics for each individual item
are presented in Table 2. This indicates that items 1 and 2
are problematic in terms of the w2 ﬁt statistic and items 2
and 3 are problematic in terms of their ﬁt residuals.
Item 2 appears to be the most problematic item. It
displays a high-negative residual and an over-discriminating
response pattern, indicating a possible redundancy or
dependency within the item set.
Local independency
Two aspects of local independency were investigated. First
the residual correlation matrix was assessed to identify
response dependencies between items. At a correlation
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indication level of 0.1, dependencies were indicated between
items 1 and 2 (r =0.25), items 3 and 4 (r = 0.14) and items 2
and 6 (r = 0.17).
Second, the t-test results (Table 1a, 1b) indicated some
evidence of multidimensionality, which could be caused by
the response dependency found within the scale.
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Table 1a Summarised analysis results of the PHQ-9
Item
location
Person
location
Item fit
residual
Person fit
residual
Chi square
interaction
PSI
with extrms/
Analysis Analysis summary Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Value (d.f.) P no extrms Alpha
Initial Nothing - initial 0 (0.821) 0.465
(1.038)
0.107 (2.01) -0.23 (1.04) 189.5 (81) 0 0.793/0.766 0.795
A Item 2 removed from initial
as part of dependent pair
0 (0.803) 0.368 (0.97) 0.162 (1.12) -0.23 (0.98) 109.9 (56)
50.0001
0.751/0.719 0.756
B Item 1 removed from initial
as part of dependent pair
0 (0.849) 0.41 (0.997) 0.123 (1.57) -0.23 (0.98) 155.6 (72) 0 0.757/0.723 0.763
C Items 1 & 2 sub-tested to
account for dependency
0 (0.803) 0.37 (0.959) -0.03 (1.84) -0.25 (0.98) 115.1 (72)
0.001
0.775/0.745 0.77
D Items 1 & 2 and 3 & 4
sub-tested to account for
dependency
0 (0.797) 0.26 (0.933) 0.015 (1.57) -0.24 (0.95) 97.04 (63)
0.004
0.768/0.735 0.756
E Items 1, 2 & 6 and 3 & 4
sub-tested to account for
dependency
0 (0.802) 0.165 (0.87) -0.07 (1.81) -0.24 (0.88) 72.81 (54)
0.045
0.75/0.713 0.709
F Item 2 removed and items
3 & 4 sub-tested to account
for dependency
0 (0.798) 0.259
(0.944)
0.252 (0.52) -0.22 (0.95) 87.25 (56)
0.005
0.745/0.707 0.733
G Items 1 & 2 removed 0 (0.83) 0.301
(0.927)
0.172 (0.96) -0.24 (0.93) 102.2 (63)
0.0013
0.704/0.669 0.717
H Items 1 & 2 removed and
Items 3 & 4 sub-tested for
dependency
0 (0.809) 0.163
(0.892)
0.299 (0.47) -0.23 (0.9) 81.82 (54)
0.0086
0.692/0.649 0.686
PHQ2 PHQ-2 items only 0 (0.42) 1.3 (2.11) 0.47 (0.31) -0.49 (0.85) 16.93 (6)
0.0095
0.606/0.45 0.757
Table 1b Summarised analysis results of the PHQ-9
Unidimensionality t-tests (CI)
Analysis Analysis summary
Significant
tests
n (%)a
Lower-
bound 95%
CI
Misfit items,
n (w2 or fit
residual)
Response-
dependent
itemsb
Initial Nothing - initial 56 (7.40) 5.80% Items 1, 2, 3 Items 1 & 2,
2 & 6, 3 & 4
A Item 2 removed from initial as part of dependent pair 37 (4.90) - Item 4 Items 3 & 4
B Item 1 removed from initial as part of dependent pair 42 (5.55) 4.00% Item 2 Items 2 & 6,
3 & 4
C Items 1 & 2 sub-tested to account for dependency 35 (4.62) - Sub-test item
1 & 2
Items 3 & 4
D Items 1 & 2 and 3 & 4 sub-tested to account for dependency 33 (4.36) - Sub-test item
1 & 2
None
E Items 1, 2 & 6 and 3 & 4 sub-tested to account for
dependency
27 (3.57) - Sub-test item
1, 2, 6
None
F Item 2 removed and items 3 & 4 sub-tested to account for
dependency
34 (4.49) - Item 1 None
G Items 1 & 2 removed 20 (2.64) - Item 4 is
borderline
Items 3 & 4
H Items 1 & 2 removed and Items 3 & 4 sub-tested for
dependency
20 (2.64) - None None
PHQ2 PHQ-2 items only 6 (0.98)c - Item 2 (w2
P=0.0243)
None
a. Total number of tests 757.
b. Items that display response dependence at a residual correlation criterion value of 0.1.
c. Total number of tests 610.
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Targeting
The person-item threshold distribution for the PHQ-9
scale is shown in Fig. 1. The scale appeared to be well
targeted to this clinical sample, with the mean person
location slightly higher than the mean item location. This
indicates that this sample was displaying a higher average
depression level than that represented by the scale (Fig. 1).
The results of the initial analysis show some potential
problems with the scale among the current sample,
although these problems are not entirely consistent with
previous research in other populations.
Part two: accounting for misfit within the model
The analyses iterations emphasise the problems that were
apparent in the initial analysis (Table 1a, 1b). Thresholds
remained ordered in all of the analyses, suggesting that all
response categories are appropriate to this sample. The
most parsimonious analysis iteration was analysis H, which
has no speciﬁc problems despite the w2 probability
displaying signiﬁcance. The overall signiﬁcant w2 value is
likely to be affected by the reasonably large sample size.
This is also the case for all of the other analyses, but
individual problems were identiﬁed within analyses A-G.
For analysis H, when the overall w2 value is adjusted
based on a sample size of 500 (available within
RUMM2030), P = 0.473. Within all analyses, once the
response dependency has been taken into account the
scale displays an acceptable level of unidimensionality. This
suggests that the initial apparent multidimensionality is due
to the response dependency that is present within the scale.
PHQ-2
Items 1 and 2 were identiﬁed as displaying response
dependency, and are potentially redundant when used in
conjunction with all other PHQ-9 items. It should be noted
that these two items make up the PHQ-2 short form.
Additional analysis was carried out on the PHQ-2; results
are reported in Table 1a and 1b.
Fit statistics displayed a degree of misﬁt, with the
overall ﬁt statistics similar to the better PHQ-9 analysis
iterations. Also, to compare the PHQ-2 short form and the
complete PHQ-9, individual person estimates were derived
from each version of the scale (when anchored to the same
metric). A t-test was then used to compare the PHQ-9 and
PHQ-2 estimates for each individual. When test-based
extremes are removed, 4 out of 757 (0.53%) individuals
display person estimates that are signiﬁcantly different at
P =0.05. When sub-test-based extremes are removed (i.e.
those that were at the ﬂoor or ceiling of the shorter PHQ-2
scale), 2 out of 620 (0.32%) individuals display person
estimates that are signiﬁcantly different at P = 0.05. This
same analysis also allows for equivalent levels of depression
to be estimated on both the PHQ-9 and the PHQ-2. This
revealed that the PHQ-9 cut-off point of 10 is equivalent to
a PHQ-2 value of 2.705.When rounded to the nearest whole
number, this is equivalent to the PHQ-2 cut-off point
ORIGINAL PAPERS
Horton & Perry Screening for depression: PHQ-9
Table 2 Individual item fit for Patient Health Questionnaire-9 (PHQ-9) items
Response category,a n (%)
Logit Fit w2
PHQ-9 item 0 1 2 3 location s.e. residual w2 d.f. probability
1 Little interest or pleasure
in doing things 35 (4.6) 252 (32.9) 277 (36.1) 203 (26.5) -0.353 0.051 -1.532 27.89 9 0.000
2 Feeling down, depressed
or hopeless 22 (2.9) 201 (26.2) 301 (39.2) 243 (31.7) -0.713 0.053 -3.697 60.166 9 0
3 Trouble falling or staying
asleep, or sleeping too much 46 (6) 99 (12.9) 222 (28.9) 400 (52.2) -0.582 0.048 2.952 13.172 9 0.154
4 Feeling tired or having
little energy 23 (3) 121 (15.8) 264 (34.4) 359 (46.8) -0.864 0.053 -1.447 16.895 9 0.050
5 Poor appetite or overeating 116 (15.1) 181 (23.6) 226 (29.5) 244 (31.8) 0.11 0.043 1.519 15.866 9 0.069
6 Feeling bad about yourself
- or that you are a failure
or have let yourself or your
family down 58 (7.6) 185 (24.1) 252 (32.9) 272 (35.5) -0.279 0.047 0.052 14.403 9 0.108
7 Trouble concentrating
on things 90 (11.7) 229 (29.9) 234 (30.5) 214 (27.9) 0.076 0.045 0.896 10.542 9 0.308
8 Moving or speaking so
slowly that other people
could have noticed. Or the
opposite - being so ﬁdgety
or restless that you have
been moving around a lot
more than usual 249 (32.5) 237 (30.9) 191 (24.9) 90 (11.7) 0.999 0.045 1.247 10.502 9 0.311
9 Thoughts that you would
be better off dead or hurting
yourself in some way 434 (56.6) 195 (25.4) 93 (12.1) 45 (5.9) 1.606 0.048 0.972 20.037 9 0.017
a. Response categories: 0, not at all; 1, several days; 2, more than half the days; 3, nearly every day.
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suggested by Kroenke et al10 as the optimal cut-off point for
depression screening purposes.
These ﬁndings offer support for the use of PHQ-2 as a
screening tool, as the person estimates of level of depression
provided by the PHQ-2 do not signiﬁcantly differ from the
estimates provided by the PHQ-9.
Discussion
The Rasch modelling process provides an integrated frame-
work to explore different measurement characteristics of a
scale. This integrated approach emphasises the relationship
between the scale items and an assumed underlying latent
construct. The Rasch model has a number of assumptions,
including that of a unidimensional structure, which assumes
that all of the items within a scale contribute to measuring
the same underlying construct. Any deviation from this
measurement structure will be identiﬁed through a series of
ﬁt statistics.15
Rasch analysis is a form of item response theory, as it is
based around the interaction of how people respond to
individual items within a scale. However, it is also often
seen as separate entity owing to the differences in the
epistemological approach. Andrich26 has broadly described
these two approaches as the ‘statistical modelling’ paradigm
(item response theory) and the ‘experimental measurement’
paradigm (Rasch), and has argued that the paradigms
are incompatible, despite their apparent similarities. A
distinctive feature of Rasch modelling is that the model is
considered a formal representation of proper measurement
and data are examined against this formal model, whereas
with a statistical modelling approach the best model is
sought to describe the data.16
To our knowledge this is the ﬁrst attempt to apply
Rasch models to a sample of primary care patients with
varying levels of depression. Research in other areas has
suggested different models for the PHQ-9, including the
PHQ-2, which has been extensively developed to reduce the
burden of time taken to identify people who may be
experiencing depression.
The main ﬁnding of the study suggests that when all
items of the PHQ-9 are taken together, then it contains
items where response dependency is present among a
sample with current depression. This is particularly
apparent between items 1 and 2 and, to a lesser extent,
between items 3 and 4. Both of these dependencies make
sense conceptually, as the contents of items 1 and 2 are
linked to the major symptoms of depression, whereas items
3 and 4 are concerned with issues of sleep and tiredness. It
should be noted that items 1 and 2 are the two items that
make up the PHQ-2 short form. This raises a question about
the potential duplication of clinical information when
items 1 and 2 are used alongside the other items within
the PHQ-9.
Previous research9 found only three items of the PHQ-9
in their ﬁnal solution: 1, 2 and 4. These core symptoms create
the core ICD-10 criteria which link to the diagnosis of
depression.9 Our research suggested that item 2 is over-
discriminating and is potentially redundant in the existing
scale. Conversely, this means that it could be seen as good
summary item for the rest of the scale items, thus offering
support for the use of the PHQ-2 as a screening tool.
However, within the Rasch measurement model framework,
the PHQ-2 items appear to be problematic when adminis-
tered alongside the other items of the PHQ-9. The PHQ-2
has been advocated by some researchers as the preferred
model of screening, with nurses reporting high satisfaction
with an average screening process and reporting time of
1-2min.11 Despite satisfaction on a practical clinical level,
the sensitivity and speciﬁcity of the PHQ-2 with a sample of
drug users in the community was shown to be poor in
relation to the PHQ-9 in people with moderate clinical
depression.12
The measurement properties of the PHQ-9 have also
been explored by attempting to generate ﬁt to the Rasch
model through combinations of removal of mis-ﬁtting items
and sub-testing to account for dependency between items.
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Fig. 1 Person-item threshold distribution, displaying the relative logit location distribution of the PHQ-9 item thresholds and the primary
care sample.
The vast majority of the sample (91%) were classiﬁed as clinically depressed by the PHQ-9.
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This analysis procedure contributes towards the further
understanding of the relationship between items of the
scale. In this case, this analysis emphasised the ﬁndings of
the initial analysis.
In summary, ordered response thresholds were never
an issue: response dependency was apparent between the
PHQ-2 items (items 1, 2), and between the sleep and
tiredness items (items 3, 4). The initial apparent multi-
dimensionality appears to be due to this dependency, and
items 1 and 2 also overdiscriminate within the PHQ-9.
Our ﬁnding is contrary to that of previous research,8
which identiﬁed one mis-ﬁtting item (item 8) that included
contrasting symptoms. Williams et al argue that including
both poles of the diagnostic criterion is confusing and is
likely to contribute to item misﬁt. Consequently, they
suggest that splitting items such as ‘poor appetite or
overeating’ is likely to reduce cognitive demands, improve
the psychometric properties, enhance speciﬁcity and
minimise the costs associated with follow-up examinations
of those who screen positive.8 However, from a psycho-
metric point of view, splitting these items is likely to result
in some dependency within the measure as the response to
‘poor appetite’ is unlikely to be independent from the
response to ‘overeating’.
Overall, it is interesting to note that the four research
studies using Rasch analysis have produced different models
for the PHQ-9 with different populations. This point
demonstrates the importance of validity within psycho-
metric testing and variability of results across different
groups of patients. For this reason, clinicians must weigh up
the pros and cons of alternative cut-off points to determine
the best ﬁt for their circumstances.
In the present study, the most parsimonious analysis
involved the removal of items 1 and 2, and accounting for
the dependency between items 3 and 4. Following these
amendments, the ﬁt to the Rasch model appeared to be
adequate. The scale appears to be well targeted to this
particular sample, but the reported reliability values are
not sufﬁcient for the PHQ-9 to be used as an outcome
measure for individual-level use. However, as the primary
function of the PHQ-9 is as a screening tool rather than as
an outcome measure, the reliability of the scale is probably
sufﬁcient.
Study limitations
The sample of participants may not fully represent the
diverse characteristics found within the wider population as
patients with the most serious depression in this study are
likely to be more severely impaired, the sample was
screened into the study without external validation, and
the purposive sampling may inﬂuence the ﬁndings of the
analysis as a sample with depression would afﬁrm items
relating to symptomatic depression. Therefore, the apparent
redundancy of the PHQ-2 items may be due to the sample
inclusion criteria. Nonetheless, the conceptual redundancy
still holds, regardless of the sampling. An improved strategy
to assess the properties of the PHQ-9 would be to
administer it to a clinically validated sample of patients
with depression; however, it was beyond the scope of this
study to collect the data in this way.
In its current format the PHQ-9 displays some
problems with regard to its measurement structure among
a sample with depression. However, these problems can be
addressed to deliver a stable screening tool. The results also
offer support for the PHQ-2 short form as a screening tool.
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Unlike many ﬁelds in medicine, most clinical outcomes in
psychiatry are not directly observable and cannot be
captured with diagnostic tests such as blood work or
imaging. In recent years, the importance of the routine
use of clinical outcome assessments (patient-reported
outcomes, clinician-reported outcomes, observer-reported
outcomes and performance outcomes) for measuring the
symptoms of disease and treatment outcomes has been
increasingly emphasised.1 Clinical outcome assessments
such as the Patient Health Questionnaire-9 (PHQ-9)2 are
now commonly used in clinical research and practice to
provide an assessment of a patient’s severity of mood and
improvement in response to treatment.3 More broadly, as
the demand increases for a broad range of mental health
services to be patient-centred, clinical outcome assessments
are used to capture outcomes such as sustained symptom
reduction, return to full functioning and optimal patient
well-being.4
To optimise mental healthcare, clinical outcome
assessments used in psychiatry should be shown to be ﬁt
for purpose. They should appropriately capture the concept
of interest (e.g. depression) in the context of use (e.g.
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Summary This commentary argues the importance of robust, meaningful
assessment of clinical and functional outcomes in psychiatry. Outcome assessments
should be ﬁt for the purpose of measuring relevant concepts of interest in speciﬁc
clinical settings. As well, the measurement model selected to develop and test
assessments can be critical for guiding care. Three types of measurement models are
presented: classical test theory, item response theory, and Rasch measurement
theory. To optimise current diagnostic and treatment practices in psychiatry, careful
consideration of these models is warranted..
Declaration of interest None.
The application of Rasch measurement theory
to psychiatric clinical outcomes research
Commentary on . . . Screening for depression in primary care{
Skye P. Barbic,1 Stefan J. Cano2
{See original paper, pp. 237-243, this issue.
243
